Ahmad Mortazavi
Chief Executive Officer en E-THERAPEUTICS PLC .
Fortuna: 9 M $ al 29/02/2024
Perfil
Founder of Evolution Securities Ltd., Ahmad Ali Mortazavi presently is Chief Executive Officer & Director at e-Therapeutics Plc.
In the past Mr. Mortazavi was Chief Executive Officer & Executive Director at Silence Therapeutics Plc, Managing Director at Alborz Darou Pharmaceutical Co. and Analyst at Crédit Lyonnais Securities Europe.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
E-THERAPEUTICS PLC
8.72% | 28/04/2023 | 50 941 666 ( 8.72% ) | 9 M $ | 29/02/2024 |
Cargos activos de Ahmad Mortazavi
Empresas | Cargo | Inicio |
---|---|---|
E-THERAPEUTICS PLC | Chief Executive Officer | 12/10/2020 |
Antiguos cargos conocidos de Ahmad Mortazavi.
Empresas | Cargo | Fin |
---|---|---|
SILENCE THERAPEUTICS PLC | Chief Executive Officer | 04/06/2018 |
Crédit Lyonnais Securities Europe | Analyst-Equity | 30/05/1999 |
Alborz Darou Pharmaceutical Co.
Alborz Darou Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Alborz Darou Pharmaceutical Co. engages in the manufacture, and marketing of pharmaceutical products. It offers its formulations and products in the form of ampoules, tablets, suspensions, syrups, capsules, prefilled syringes, and soft liquids. The company was founded in 1976 and is headquartered in Tehran, Iran. | Chief Executive Officer | - |
Evolution Securities Ltd. | Founder | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 3 |
---|---|
E-THERAPEUTICS PLC | Health Technology |
SILENCE THERAPEUTICS PLC | Commercial Services |
Health Technology |
Empresas privadas | 2 |
---|---|
Evolution Securities Ltd. | Finance |
Crédit Lyonnais Securities Europe | Finance |